Quick Takeaways
- Jaguar Health announced the planned launch of Neonorm Dog, a plant-based, non-prescription product designed to support normal stool formation, gut hydration, and bowel health in dogs, expanding the company’s Neonorm franchise for companion animals
- The Neonorm franchise currently includes Neonorm Foal and Neonorm Calf for pre-weaned foals and calves. The products contain a standardized botanical extract derived from the sustainably harvested Croton lechleri tree and are designed to act locally in the gut
- The expansion aligns with Jaguar’s broader gastrointestinal-focused animal health strategy, which includes Canalevia-CA1, conditionally approved by the FDA for chemotherapy-induced diarrhea in dogs. Neonorm Dog is expected to be launched through select online and animal health retail channels following completion of packaging, labeling, and commercial launch preparations
Why It Matters?
Jaguar is extending its rainforest‑derived GI platform from niche equine/calf use into the much larger companion‑dog market with Neonorm Dog, giving it an OTC, plant‑based gut‑health brand that can sit alongside its prescription Canalevia‑CA1 oncology asset.
Source: Jaguar Health
